Previous 10 | Next 10 |
Cerecor (NASDAQ: CERC ) has entered into an underwriting agreement with Oppenheimer & Co. Inc. for the issuance of 13.2M common stock at $2.50/share, for gross proceeds of ~$33M. More news on: Cerecor Inc., Healthcare stocks news, , Stocks on the move, Read more ...
ROCKVILLE, Md., June 09, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today that it has entered into an underwriting agreeme...
ROCKVILLE, Md., June 08, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today that it intends to offer for sale shares of its ...
TransMedics Reports Positive Data from PROTECT Trial TransMedics Group Inc. ( TMDX ) announced that it has received positive data from its US pivotal OCS Liver PROTECT Trial. The study is a multicenter, two-armed, prospective trial for assessing the effectiveness and safety of the OCS Li...
ROCKVILLE, Md., May 29, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 2:30 p.m. EDT. A live webcast of the presentat...
ARCA biopharma (NASDAQ: ABIO ) +59% on launching AB201 program in COVID-19. More news on: ARCA biopharma, Inc., PhaseBio Pharmaceuticals, Inc., Technical Communications Corporation, Stocks on the move, , Read more ...
Cerecor (NASDAQ: CERC ) has received FDA clearance to proceed with a proof-of-concept clinical trial of its anti-LIGHT monoclonal antibody CERC-002 in patients with COVID-19 cytokine storm induced Acute Respiratory Distress Syndrome (ARDS). More news on: Cerecor Inc., Healthcare stocks n...
Company to Initiate Multicenter, Placebo-controlled, Randomized Study in June Top-line Data Anticipated in Fourth Quarter 2020 ROCKVILLE, Md., May 28, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and comm...
Mmtec (NASDAQ: MTC ) +168% on FY results . More news on: Mmtec, Inc., Sky Solar Holdings, Ltd., Cellectar Biosciences, Inc., Stocks on the move, , Read more ...
Cerecor (NASDAQ: CERC ) and Myriad Genetics (NASDAQ: MYGN ) announce that levels of a novel cytokine called LIGHT is highly correlated with disease severity and mortality in COVID-19 patients with acute respiratory distress syndrome (ARDS). The data were generated in a biomarker stud...
News, Short Squeeze, Breakout and More Instantly...
Cerecor Inc. Company Name:
CERC Stock Symbol:
NASDAQ Market:
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical Officer. “We are thrilled to have Mittie join and grow our leadership team at an exciting...
Following FDA review, Avalo’s IND application for AVTX-009 is active allowing Avalo to proceed with its Phase 2 trial (LOTUS) to evaluate the efficacy and safety of AVTX-009 in patients with hidradenitis suppurativa WAYNE, Pa. and ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- Ava...
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present on the Novel Immunological Mechanisms for Dermatological Disorders Panel being held at...